Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2026-02-06

Clinical Trial Update: Prediction of Hepatocellular Carcinoma Recurrence After Curative Treatment by Monitoring Circulating Tumor DNA [NA]

View source ↗

Summary

A clinical trial is investigating whether monitoring circulating tumor DNA can predict recurrence of hepatocellular carcinoma after curative treatment. The stud…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: University Hospital, Rouen | Conditions: Hepatocellular Carcinoma | NA | Status: RECRUITING